Prostate cancer

breathcrumb

Prostate cancer

Prostate Cancer Biomarkers

Increasing levels


  • Increased core fucosylation and increase a2,3-sialic acid compared with BPH patients serum.
  • G0 significantly increased and G1 and α2-6 syalilation decreased in the IgG heavy chains of patients with prostate cancer.
  • Glycan Standard 13C Biantennary A1(3) (Sial α-2,3)
  • Glycan Standard 13C Tetraantennary A4-G1a
  • Bis α-2,6-sialylated biantennary glycopeptide from egg yolk
  • Bis α-2,3-sialylated, galactosylated biantennary glycopeptide

Prostate Cancer Biomarkers

Decreasing levels


  • Decreased sialylation of PSA subforms in seminal plasma.
  • Poor prognosis is associated with decreased levels of fucosylated glycans and increased levels of sialylated compounds.
  • Bis α-2,3-sialylated, galactosylated biantennary glycopeptide